iTeos Announces 2025 Strategic Priorities and Anticipated Milestones
Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - ...
Kotak Fund invests ₹940 crore in IPO-bound Neuberg Diagnostics
Kotak Strategic Situations India Fund II invests ₹940 crore in Neuberg Diagnostics for expansion and IPO preparation.
Medindia24m
Ouro Medicines Launches to Define the Future of Treatment for People with Immune-Mediated Diseases
Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, ...
BioPharma Dive36m
Ouro, backed by GSK, joins hunt to bring bispecifics to autoimmune disease
Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...
Alzheimer’s could be diagnosed 10 years earlier after world’s largest blood proteins study
Alzheimer’s could be diagnosed 10 years earlier after world’s largest blood proteins study - UK based project could pave way ...
expresshealthcare13m
Kotak alternate asset managers invests INR 940 crore in Neuberg Diagnostics
Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited (Kotak Alt), has announced an ...